Back

Prophylactic combined heart failure treatment attenuates the development of doxorubicin induced systolic and diastolic dysfunction in rats

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 1 - Basic Science Animal models and experimentation HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Miss Maria Lodi

University of Debrecen, Debrecen (Hungary)

13 More presentations in this session

Presentation thumbnail
Epac1-mediated RE/mitochondria interactions promotes mitochondrial Ca2+ overload and cell death during ischemia/reperfusion injury
Miss L. Fazal (Paris, FR)
Abstract
Presentation thumbnail
Intramyocardial delivery of mesenchymal stem cells transfected with minicircle-HIF-1a decreases LV adverse remodelling via release of cardioprotective miRNAs and pro-angiogenic factors
Doctor E. Gara (Budapest, HU)
Abstract
Presentation thumbnail
NPA7, an innovative multivalent designer natriuretic peptide: Co-therapy with Furosemide to mediate renoprotection in experimental ADHF
Doctor L. Meems (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Eosinophils have an essential role in promoting a type 2 innate immune response and cardiac repair following myocardial infarction.
Presentation thumbnail
NADPH oxidase-4 promotes adaptive cardiac remodelling in the chronically stressed heart by driving protein O-GlcNAcylation and enhancing cardiac fatty acid oxidation
Doctor A. Nabeebaccus (London, GB)
Abstract

Access the full session

Session thumbnail
Rapid Fire 1 - Basic Science

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources